Dinesh Khanna Selected Research

ametantrone (HAQ)

1/2017	Points to consider for designing trials in systemic sclerosis patients with arthritic involvement.
1/2017	Racial differences in health-related quality of life and functional ability in patients with gout.
1/2016	Performance of Gout Impact Scale in a longitudinal observational study of patients with gout.
3/2013	Dyspnea assessment and pulmonary hypertension in patients with systemic sclerosis: utility of the University of California, San Diego, Shortness of Breath Questionnaire.
7/2012	Improved health-related quality of life and physical function in patients with refractory chronic gout following treatment with pegloticase: evidence from phase III randomized controlled trials.
2/2012	Work productivity in scleroderma: analysis from the University of California, Los Angeles scleroderma quality of life study.
7/2011	Prevalence and correlates of sleep disturbance in systemic sclerosis--results from the UCLA scleroderma quality of life study.
6/2009	Validating and assessing the sensitivity of the Health Assessment Questionnaire-Disability Index-derived Short Form-6D in patients with early aggressive rheumatoid arthritis.
2/2009	The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials.
5/2008	Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dinesh Khanna Research Topics

Disease

84	Systemic Scleroderma (Systemic Sclerosis) 05/2022 - 02/2005
41	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 02/2005
31	Fibrosis (Cirrhosis) 05/2022 - 04/2009
26	Rheumatoid Arthritis 01/2016 - 01/2004
19	Gout 01/2021 - 03/2010
16	Diffuse Scleroderma (Progressive Systemic Sclerosis) 11/2021 - 01/2007
15	Pulmonary Arterial Hypertension 10/2022 - 11/2013
12	Dyspnea (Shortness of Breath) 01/2019 - 02/2005
9	Inflammation (Inflammations) 05/2022 - 06/2007
8	digital ulcers 10/2022 - 10/2009
7	Arthritis (Polyarthritis) 01/2019 - 08/2003
6	Contracture 11/2018 - 06/2010
6	Skin Diseases (Skin Disease) 07/2018 - 08/2003
6	Pulmonary Hypertension 09/2017 - 05/2007
6	Fatigue 01/2016 - 12/2008
5	Lung Diseases (Lung Disease) 06/2020 - 05/2007
5	Pain (Aches) 01/2017 - 02/2009
4	Connective Tissue Diseases (Connective Tissue Disease) 01/2021 - 12/2013
4	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 09/2005
4	Infections 12/2020 - 06/2016
4	Chronic Disease (Chronic Diseases) 02/2019 - 06/2007
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2017 - 03/2012
4	Telangiectasis (Telangiectasia) 06/2014 - 03/2012
3	Sclerosis 01/2022 - 04/2009
3	Disease Progression 11/2020 - 01/2018
3	Calcinosis 10/2020 - 03/2012
3	Anemia 01/2019 - 01/2014
3	Heart Failure 01/2017 - 01/2004
3	Rheumatic Diseases (Rheumatism) 01/2016 - 09/2005
2	Cough 11/2022 - 04/2017
2	Melanoma (Melanoma, Malignant) 01/2022 - 04/2019
2	Demyelinating Diseases (Demyelinating Disease) 10/2021 - 01/2004
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 09/2005
2	Chronic Renal Insufficiency 01/2020 - 01/2020
2	Idiopathic Pulmonary Fibrosis 01/2020 - 01/2019
2	Cytopenia 01/2019 - 02/2010
2	Muscle Weakness 01/2019 - 01/2017
2	Gastroesophageal Reflux (GERD) 04/2017 - 03/2012
2	Hypertension (High Blood Pressure) 01/2017 - 04/2014
2	Skin Ulcer 01/2017 - 05/2016
2	Ulcer 01/2017 - 03/2012
2	Headache (Headaches) 05/2016 - 01/2016

Drug/Important Bio-Agent (IBA)

21	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2021 - 02/2005
15	ametantrone (HAQ)IBA 01/2017 - 05/2005
13	Carbon MonoxideIBA 12/2021 - 02/2005
13	Uric Acid (Urate)IBA 01/2021 - 03/2010
11	Biomarkers (Surrogate Marker)IBA 05/2022 - 10/2009
10	tocilizumab (atlizumab)FDA Link 01/2022 - 06/2016
9	Mycophenolic Acid (Cellcept)FDA LinkGeneric 06/2021 - 01/2016
8	AutoantibodiesIBA 01/2022 - 11/2013
8	Antirheumatic Agents (DMARD)IBA 03/2020 - 08/2003
7	Methotrexate (Mexate)FDA LinkGeneric 06/2021 - 10/2005
7	Febuxostat FDA Link 01/2020 - 03/2014
6	Biological ProductsIBA 05/2022 - 01/2004
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2009 - 01/2004
5	CytokinesIBA 05/2022 - 01/2004
5	Pharmaceutical PreparationsIBA 09/2021 - 01/2004
5	Abatacept (Orencia)FDA Link 06/2021 - 01/2016
5	Allopurinol (Remid)FDA LinkGeneric 01/2020 - 07/2011
4	nintedanibIBA 11/2022 - 01/2021
4	riociguatIBA 01/2022 - 01/2017
4	Bleomycin (Blenoxane)FDA LinkGeneric 04/2019 - 01/2017
4	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2016 - 08/2003
4	Certolizumab Pegol FDA Link 07/2012 - 05/2010
3	Monoclonal AntibodiesIBA 05/2022 - 11/2006
3	anti-scl-70 autoantibodiesIBA 09/2021 - 03/2012
3	GlucocorticoidsIBA 06/2021 - 01/2020
3	Pegloticase FDA Link 01/2021 - 07/2012
3	Rituximab (Mabthera)FDA Link 01/2021 - 01/2010
3	Antinuclear AntibodiesIBA 01/2021 - 03/2012
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2018
3	Interleukin-6 (Interleukin 6)IBA 10/2020 - 04/2014
3	Colchicine FDA LinkGeneric 01/2020 - 08/2014
3	CollagenIBA 02/2019 - 01/2014
3	C-Reactive ProteinIBA 01/2019 - 06/2005
3	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2019 - 12/2013
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018 - 11/2011
3	Imatinib Mesylate (Gleevec)FDA Link 01/2018 - 11/2011
3	Etanercept (Enbrel)FDA Link 07/2007 - 07/2003
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 09/2021 - 06/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2021
2	Iloprost (Ventavis)FDA Link 01/2021 - 02/2019
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 01/2017
2	AntibodiesIBA 01/2021 - 06/2014
2	CalciumIBA 10/2020 - 04/2008
2	EnzymesIBA 04/2020 - 06/2007
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2018
2	Antifibrotic AgentsIBA 01/2019 - 01/2019
2	lesinuradIBA 01/2019 - 01/2017
2	rilonacept FDA Link 07/2018 - 07/2011
2	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2017 - 02/2014
2	CreatinineIBA 01/2017 - 04/2009
2	Endothelin Receptor AntagonistsIBA 01/2017 - 05/2007
2	Tumor Necrosis Factor InhibitorsIBA 09/2016 - 05/2010
2	antineoplaston A10 (A 10)IBA 02/2016 - 01/2016
2	Adalimumab (Humira)FDA Link 01/2016 - 11/2006

Therapy/Procedure

54	Therapeutics 01/2022 - 04/2004
3	Ambulatory Care (Outpatient Care) 01/2017 - 12/2008
2	Occupational Therapy (Therapy, Occupational) 11/2021 - 11/2018
2	Operative Surgical Procedures 09/2016 - 04/2016